dc.contributor.author | Topal, Hatice | |
dc.contributor.author | Topal, Yasar | |
dc.date.accessioned | 2020-11-20T16:19:04Z | |
dc.date.available | 2020-11-20T16:19:04Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 2074-1804 | |
dc.identifier.issn | 2074-1812 | |
dc.identifier.uri | https://doi.org/10.5812/ircmj.12718 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12809/3688 | |
dc.description | WOS: 000333960400021 | en_US |
dc.description | PubMed ID: 24693390 | en_US |
dc.description.abstract | Methemoglobinemia is a disorder characterized by the presence of a higher than normal level of methemoglobin. Prilocaine which is one of the oxidizing local anaesthetics is widely used in many local procedures. The first choice of treatment of complications due to the use of these local anaesthetics is methylene blue, while ascorbic acid is the alternative choice. The side effects of metilen blue restrict its usage in some special conditions. Ascorbic acid is a good alternative drug with limited experience in methemoglobinemia. We present a case of a methemoglobinemia treated with ascorbic acid successfully to emphasize the use of ascorbic acid as an alternative method. | en_US |
dc.item-language.iso | eng | en_US |
dc.publisher | Kowsar Publ | en_US |
dc.item-rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Methemoglobinemia | en_US |
dc.subject | Prilocaine | en_US |
dc.subject | Ascorbic Acid | en_US |
dc.title | Toxic Methemoglobinemia Treated With Ascorbic Acid: Case Report | en_US |
dc.item-type | article | en_US |
dc.contributor.department | MÜ | en_US |
dc.contributor.departmentTemp | [Topal, Hatice; Topal, Yasar] Mugla Sitki Kocman Univ, Fac Med, Dept Pediat, Mugla, Turkey | en_US |
dc.identifier.doi | 10.5812/ircmj.12718 | |
dc.identifier.volume | 15 | en_US |
dc.identifier.issue | 12 | en_US |
dc.relation.journal | Iranian Red Crescent Medical Journal | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |